Work

A phase I study of sirolimus (rapamycin) and bevacizumab in patients with advanced malignancies.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.2591

Authors: E. E. Cohen, M. Sharma, L. A. Janisch, W. M. Stadler, S. P. Kang, G. F. Fleming, M. J. Ratain

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2299709214

Cites:

Cited by: 2

Related to: 10